KSC · 016580.KS
Whan In Pharm Co.,Ltd.
₩10,400-₩80 (-0.76%)
Whan In Pharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.33% below the high.
Loading market information…
KSC · 293480.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Hana Pharm Co., Ltd.’s forward annual dividend is ₩260 per share, paid annual. The forward yield is 3.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Hana Pharm Co., Ltd.’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hana Pharm Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic categories, such as anesthetics, potent narcotic pain relievers, anti-nausea agents, muscle relaxants, and treatments targeting the cardiovascular, endocrine, gastrointestinal, respiratory, and central nervous systems. Furthermore, the company offers antibiotics, dermatological preparations, urological medications, osteoporosis therapies, and medications for pain, fever, and inflammation. The firm was established in 1958 and has its corporate headquarters located in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 | Nov 15, 2024 | ₩171 | ₩57.25B+0.44% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩10,400-₩80 (-0.76%)
Whan In Pharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.33% below the high.
₩9,370+₩10 (+0.11%)
REYON Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.02% below the high.
₩7,650-₩40 (-0.52%)
Samil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.51% below the high.
₩10,510-₩80 (-0.76%)
JW Lifescience Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩21,150-₩650 (-2.98%)
Ilsung Is Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.82% below the high.
₩5,100-₩60 (-1.16%)
Dongwha Pharm.Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩8,600-₩230 (-2.6%)
Jeil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 55.42% below the high.
₩6,960+₩50 (+0.72%)
Ilyang Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
